Aventus Care: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Aventus Care
Largest movements
- Receivables within one year +€19,451
up €19,451 (+11.9%), from €163,722 to €183,173
of which Trade receivables: +€45,489
- Cash -€16,957
down €16,957 (-29.3%), from €57,916 to €40,959
mainly Receivables within one year (-€19,451) and Trade debts (-€3,277)
- Accrued charges and deferred income +€5,374
up €5,374 (+17.2%), from €31,273 to €36,647
- Trade debts -€3,277
down €3,277 (-4.1%), from €79,709 to €76,432
- Financial income -€3,070
down €3,070 (-32.3%), from €9,503 to €6,433
- Staff costs +€2,238
up €2,238 (+622%), from €360 to €2,597
- Gross operating margin -€1,515
down €1,515 (-129%), from -€1,172 to -€2,686
- Other operating charges -€92
down €92 (-58.4%), from €158 to €66
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €223,385 | €225,913 | +€2,528 | +1.1% |
| Current assets | 29/58 | €223,385 | €225,913 | +€2,528 | +1.1% |
| Amounts receivable within one year | 40/41 | €163,722 | €183,173 | +€19,451 | +11.9% |
| Trade receivables | 40 | €54,389 | €99,878 | +€45,489 | +83.6% |
| Other amounts receivable | 41 | €109,333 | €83,295 | -€26,037 | -23.8% |
| Cash at bank and in hand | 54/58 | €57,916 | €40,959 | -€16,957 | -29.3% |
| Deferred charges and accrued income | 490/1 | €1,748 | €1,781 | +€33 | +1.9% |
| Total equity and liabilities | 10/49 | €223,385 | €225,913 | +€2,528 | +1.1% |
| Equity | 10/15 | €112,403 | €112,834 | +€431 | +0.4% |
| Profit (loss) carried forward | 14 | €112,403 | €112,834 | +€431 | +0.4% |
| Amounts payable | 17/49 | €110,983 | €113,079 | +€2,097 | +1.9% |
| Amounts payable within one year | 42/48 | €79,709 | €76,432 | -€3,277 | -4.1% |
| Trade debts | 44 | €79,709 | €76,432 | -€3,277 | -4.1% |
| Suppliers | 440/4 | €79,709 | €76,432 | -€3,277 | -4.1% |
| Accrued charges and deferred income | 492/3 | €31,273 | €36,647 | +€5,374 | +17.2% |
| Remuneration, social security and pensions | 62 | €360 | €2,597 | +€2,238 | +622% |
| Other operating charges | 640/8 | €158 | €66 | -€92 | -58.4% |
| Gross operating margin | 9900 | -€1,172 | -€2,686 | -€1,515 | -129% |
| Operating profit (loss) | 9901 | -€1,689 | -€5,349 | -€3,660 | -217% |
| Financial income | 75/76B | €9,503 | €6,433 | -€3,070 | -32.3% |
| Recurring financial income | 75 | €9,503 | €6,433 | -€3,070 | -32.3% |
| Financial charges | 65/66B | €647 | €653 | +€6 | +0.9% |
| Recurring financial charges | 65 | €647 | €653 | +€6 | +0.9% |
| Profit (loss) for the period before taxes | 9903 | €7,167 | €431 | -€6,736 | -94.0% |
| Income taxes | 67/77 | €0 | €0 | = | 0.0% |
| Profit (loss) for the period | 9904 | €7,167 | €431 | -€6,736 | -94.0% |
| Profit (loss) for the period to be appropriated | 9905 | €7,167 | €431 | -€6,736 | -94.0% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.